GetTopicDetailResponse(id=777f9e63e8, topicName=imlifidase, introduction=imlifidase, content=null, image=null, comments=2, allHits=917, url=https://h5.medsci.cn/topic?id=9763, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=77941, tagList=[TagDto(tagId=77941, tagName=imlifidase)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1613687, encodeId=ae4f161368e03, content=<a href='/topic/show?id=777f9e63e8' target=_blank style='color:#2F92EE;'>#imlifidase#</a>, objectTitle=Hansa Biopharma宣布?xì)W洲藥品管理局接受IDEFIRIX（imlifidase）用于高度敏感的腎移植患者的營銷授權(quán)申請, objectType=article, longId=161543, objectId=416d16154305, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=416d16154305, replyNumber=0, likeNumber=81, createdTime=2019-03-04, rootId=0, userName=1249862am78(暫無昵稱), userId=e5f619414207, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=416d16154305, moduleTitle=Hansa Biopharma宣布?xì)W洲藥品管理局接受IDEFIRIX（imlifidase）用于高度敏感的腎移植患者的營銷授權(quán)申請, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=416d16154305)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1613686, encodeId=31a2161368630, content=<a href='/topic/show?id=777f9e63e8' target=_blank style='color:#2F92EE;'>#imlifidase#</a>, objectTitle=Hansa Medical的imlifidase（IdeS）獲FDA批準(zhǔn)用于抗GBM疾病的治療, objectType=article, longId=144572, objectId=83311445e263, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83311445e263, replyNumber=0, likeNumber=104, createdTime=2018-07-18, rootId=0, userName=1249862am78(暫無昵稱), userId=e5f619414207, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83311445e263, moduleTitle=Hansa Medical的imlifidase（IdeS）獲FDA批準(zhǔn)用于抗GBM疾病的治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=83311445e263)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
